Surgery for pancreatic cancer with limited liver spread after chemo
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial is for people with pancreatic cancer that has spread to the liver (3 spots or fewer). It tests whether removing both the original tumor and the liver spots after a specific chemotherapy (FOLFIRINOX) can be helpful. You may be eligible if the chemo shrinks the tumors enough and you are healthy enough for surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a type of pancreatic cancer called pancreatic ductal adenocarcinoma.
- The main tumor in your pancreas can be removed by surgery.
- You have 3 or fewer liver spots (metastases).
- You have no cancer spread to other parts of the body outside the liver.
- After chemotherapy with FOLFIRINOX, your tumors have shrunk or stayed the same, and no new spots have appeared.
- You are in good physical condition (able to do daily activities without help).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study looks at different types (subtypes) of pancreatic tumors in people treated with FOLFIRINOX, a chemotherapy. It requires tumor biopsies before and after treatment to see how the tumor changes, which may help doctors better match treatments in the future.
This trial compares surgery to remove the primary tumor and up to 3 liver spots against standard palliative care for people with pancreatic cancer that has spread only to the liver (up to 3 spots). It is for those whose cancer has not grown after initial chemotherapy and who are healthy enough for surgery.
This trial tests whether removing or ablating limited liver or lung tumors from pancreatic cancer that has not spread elsewhere, along with a specific chemotherapy (NALIRIFOX), can help patients. It is for people who have not had any previous cancer treatment.
This study tests whether surgery to remove liver tumors from pancreatic cancer can improve outcomes. It is for patients whose cancer has spread only to the liver, and the tumor can be safely removed or destroyed.
This trial tests a treatment for pancreatic cancer that has spread to the liver (with no more than a few liver tumors). Patients will receive chemotherapy plus surgery and a heat-based procedure (thermal ablation) to destroy the liver tumors. The goal is to see if combining these treatments helps control the cancer better than chemotherapy alone.
This trial tests a combination of standard chemotherapy, MRI-guided radiation, and surgery for people with locally advanced pancreatic cancer that might be removable. The goal is to see if this approach can make more tumors resectable.
Hear when a new Pancreas Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.